Skip to content

Cocoa Flavanol and Coronary Vasomotion Vascular Function in Patients With Coronary Artery Disease

Effect of Cocoa Flavanol-containing Drink on Coronary Vascular Function in Patients With Coronary Artery Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02520466
Enrollment
37
Registered
2015-08-11
Start date
2012-07-31
Completion date
2018-12-01
Last updated
2019-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stable Coronary Heart Disease

Brief summary

The aim of the present study is to investigate whether the ingestion of a cocoa flavanol-containing drink compared to a flavanol-free drink, improves coronary vasomotion and platelet function in patients with overt coronary artery disease acutely (after 2 hours)

Interventions

DIETARY_SUPPLEMENTflavanol-rich drink vs flavanol-free drink

Patients will be randomized to either a flavanol-rich drink or a flavanol-free drink of similar volume, taste and calory and sugar content

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Patients with coronary artery disease undergoing elective coronary angiography with or without the need of coronary intervention * Age 20 - 80 * Written obtained informed consent

Exclusion criteria

* Acute ST-elevation myocardial infarction * Acute non-ST-elevation myocardial infarction (enzyme positive) * Ventricular tachy-arrythmias or AV-Block \>I° * Renal insufficiency (GFR MDRD \< 30ml/min) or liver disease (ALT or AST \>150 IU) * Pregnancy * Known allergy to compounds of cocoa product * Known allergy to contrast media * Known allergy to nuts * Intolerance to coffein and theobromin * Acute infectious disease * Disease with systemic inflammation (e.g. rheumatoid arthritis, M. Crohn) * Participation in another study within the last month * Concomitant vitamin supplements and herbal remedies, as well as fruit and tea extracts * No study visits ± 1 week before Eastern, Christmas and New Year holyday (altered eating habits) * Extreme eating habits (as assessed by a questionnaire) * Alcohol or drug abuse * Lactose intolerance

Design outcomes

Primary

MeasureTime frameDescription
coronary endothelial function as assessed as response to cold pressor test2 hoursPrimary endpoint will be the improvement in coronary endothelial function in response to cold pressor testing (i.e. % reduction in coronary artery constriction compared to baseline) 2h after ingestion of a cocoa flavanol rich-drink or placebo drink, respectively. In a subset of patients daily consumption of a flavanol-drink will be assessed and outcomes measured after 3-4 weeks.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026